SEARCH

SEARCH BY CITATION

References

  • AIRIO, J. & AHTEE, L. (1999). The involvement of noradrenergic transmission in the morphine-induced locomotor hyperactivity in mice withdrawn from repeated morphine treatment. Br. J. Pharmacol., 126, 16091619.
  • ALBERTI, K., WOODS, H. & WHALLEY, M. (1973). Mechanism of action of the monoguanidine hypoglaemic agents, galegine and agmatine. Eur. J. Clin. Invest., 3, 208.
  • ALEMANY, R., OLMOS, G., ESCRIBA, P.V., MENARGUES, A., OBACH, R. & GARCIA-SEVILLA, J.A. (1995). LSL 60101, a selective ligand for imidazoline I2 receptors, on glial fibrillary acidic protein concentration. Eur. J. Pharmacol., 280, 205210.
  • ALLAN, D.R., PENNER, S.B. & SMYTH, D.D. (1993). Renal imidazoline preferring sites and solute excretion in the rat. Br. J. Pharmacol., 108, 870875.
  • ALLAN, D.R., PENNER, S.B. & SMYTH, D.D. (1996). Antagonism by idazoxan at low dose but not high dose, of the natriuretic action of moxonidine. Br. J. Pharmacol., 117, 2934.
  • ALTMAN, J.D., TRENDELENBURG, A.U., MACMILLAN, L., BERNSTEIN, D., LIMBIRD, L., STARKE, K., KOBILKA, B.K. & HEIN, L. (1999). Abnormal regulation of the sympathetic nervous system in alpha2A- adrenergic receptor knockout mice. Mol. Pharmacol., 56, 154161.
  • ARICIOGLU-KARTAL, F. & UZBAY, I.T. (1997). Inhibitory effect of agmatine on naloxone-precipitated abstinence syndrome in morphine dependent rats. Life Sci., 61, 17751781.
  • ATLAS, D. (1991). Clonidine-displacing substance (CDS) and its putative imidazoline receptor. New leads for further divergence of alpha 2-adrenergic receptor activity. Biochem. Pharmacol., 41, 15411549.
  • ATLAS, D. (1994). Identifying clonidine-displacing substance. Science, 266, 462464.
  • ATLAS, D. (1995). Molecular and physiological properties of clonidine-displacing substance. Ann. N.Y. Acad. Sci., 763, 314324.
  • ATLAS, D. & BURSTEIN, Y. (1984a). Isolation and partial purification of a clonidine-displacing endogenous brain substance. Eur. J. Biochem., 144, 287293.
  • ATLAS, D. & BURSTEIN, Y. (1984b). Isolation of an endogenous clonidine-displacing substance from rat brain. FEBS Lett., 170, 387390.
  • ATLAS, D., DIAMANT, S., FALES, H.M. & PANNELL, L. (1987). The brain's own clonidine: purification and characterization of endogenous clonidine displacing substance from brain. J. Cardiovasc. Pharmacol., 10 (Suppl 12): S122S127.
  • AUGUET, M., VIOSSAT, I., MARIN, J.G. & CHABRIER, P.E. (1995). Selective inhibition of inducible nitric oxide synthase by agmatine. Jpn. J. Pharmacol., 69, 285287.
  • BERDEU, D., GROSS, R., RIBES, G., LOUBATIERES-MARIANI, M.M. & BERTRAND, G. (1994). Effects of imidazolines and derivatives on insulin secretion and vascular resistance in perfused rat pancreas. Eur. J. Pharmacol., 254, 119125.
  • BERDEU, D., PUECH, R., LOUBATIERES-MARIANI, M.M. & BERTRAND, G. (1996). Agmatine is not a good candidate as endogenous ligand for imidazoline sites of pancreatic B cells and vascular bed. Eur. J. Pharmacol., 308, 301304.
  • BERDINSKIKH, N.K., IGNATENKO, N.A., ZALETOK, S.P., GANINA, K.P. & CHORNIY, V.A. (1991). Ornithine decarboxylase activity and polyamine content in adenocarcinomas of human stomach and large intestine. Int. J. Cancer, 47, 496498.
  • BERENDSE, H.W. & GROENEWEGEN, H.J. (1991). Restricted cortical termination fields of the midline and intralaminar thalamic nuclei in the rat. Neuroscience, 42, 73102.
  • BHANDARE, P.N., RATABOLI, P.V. & D'SOUZA, R.S. (1991). Dual action of clonidine on ethanol-induced gastric lesions: is the imidazoline-preferring receptor involved Eur. J. Pharmacol., 199, 243245.
  • BIDET, M., TAUC, M., KOECHLIN, N. & POUJEOL, P. (1990). Video microscopy of intracellular pH in primary cultures of rabbit proximal and early distal tubules. Pflugers Arch., 416, 270280.
  • BLACHIER, F., SELAMNIA, M., ROBERT, V., M'RABET-TOUIL, H. & DUEE, P.H. (1995). Metabolism of L-arginine through polyamine and nitric oxide synthase pathways in proliferative or differentiated human colon carcinoma cells. Biochim. Biophys. Acta., 1268, 255262.
  • BLANDIZZI, C., BERNARDINI, M.C., NATALE, G. & DEL TACCA, M. (1990a). Alpha 2-adrenoceptor-mediated inhibitory and excitatory effects of detomidine on rat gastric acid secretion. J. Pharm. Pharmacol., 42, 685688.
  • BLANDIZZI, C., BERNARDINI, M.C., VIZI, E.S. & DEL TACCA, M. (1990b). Modulation of gastric acid secretion by peripheral presynaptic alpha 2- adrenoceptors at both sympathetic and parasympathetic pathways. J. Auton. Pharmacol., 10, 305312.
  • BLANDIZZI, C., NATALE, G., COLUCCI, R., CARIGNANI, D., LAZZERI, G. & DEL TACCA, M. (1995). Characterization of alpha 2-adrenoceptor subtypes involved in the modulation of gastric acid secretion. Eur. J. Pharmacol., 278, 179182.
  • BLASCHKO, H. (1974). The natural history of amine oxidases. Rev. Physiol. Biochem. Pharmacol., 70, 83148.
  • BOCK, C., NIEDERHOFFER, N. & SZABO, B. (1999). Analysis of the receptor involved in the central hypotensive effect of rilmenidine and moxonidine. Naunyn Schmiedebergs Arch. Pharmacol., 359, 262271.
  • BORONAT, M.A., OLMOS, G. & GARCIA-SEVILLA, J.A. (1998). Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other 12-imidazoline ligands. Br. J. Pharmacol., 125, 175185.
  • BOUSQUET, P., FELDMAN, J. & ATLAS, D. (1986). An endogenous, non-catecholamine clonidine antagonist increases mean arterial blood pressure. Eur. J. Pharmacol., 124, 167170.
  • BOUSQUET, P., FELDMAN, J. & ATLAS, D. (1987). Central cardiovascular effects of a noncatecholamine endogenous ligand for clonidine receptors. J. Cardiovasc. Pharmacol., 10 (Suppl 12): S167S171.
  • BOUSQUET, P., FELDMAN, J. & SCHWARTZ, J. (1984). Central cardiovascular effects of alpha adrenergic drugs: differences between catecholamines and imidazolines. J. Pharmacol. Exp. Ther., 230, 232236.
  • BRADLEY, K.J. & HEADLEY, P.M. (1997). Effect of agmatine on spinal nociceptive reflexes: lack of interaction with alpha2-adrenoceptor or mu-opioid receptor mechanisms. Eur. J. Pharmacol., 331, 133138.
  • BRICCA, G., DONTENWILL, M., MOLINES, A., FELDMAN, J., BELCOURT, A. & BOUSQUET, P. (1989). The imidazoline preferring receptor: binding studies in bovine, rat and human brainstem. Eur. J. Pharmacol., 162, 19.
  • BRICCA, G., ZHANG, J., GRENEY, H., DONTENWILL, M., STUTZMANN, J., BELCOURT, A. & BOUSQUET, P. (1993). Relevance of the use of [3H]-clonidine to identify imidazoline receptors in the rabbit brainstem. Br. J. Pharmacol., 110, 15371543.
  • BROWN, C.A., CHAN, S.L., STILLINGS, M.R., SMITH, S.A. & MORGAN, N.G. (1993b). Antagonism of the stimulatory effects of efaroxan and glibenclamide in rat pancreatic islets by the imidazoline, RX801080. Br. J. Pharmacol., 110, 10171022.
  • BROWN, C.A., LOWETH, A.C., SMITH, S.A. & MORGAN, N.G. (1993a). Stimulation of insulin secretion by imidazoline compounds is not due to interaction with non-adrenoceptor idazoxan binding sites. Br. J. Pharmacol., 108, 312317.
  • BROWN, C.M., MACKINNON, A.C., MCGRATH, J.C., SPEDDING, M. & KILPATRICK, A.T. (1990). Alpha 2-adrenoceptor subtypes and imidazoline-like binding sites in the rat brain. Br. J. Pharmacol., 99, 803809.
  • BUCCAFUSCO, J.J., LAPP, C.A., WESTBROOKS, K.L. & ERNSBERGER, P. (1995). Role of medullary I1-imidazoline and alpha 2-adrenergic receptors in the antihypertensive responses evoked by central administration of clonidine analogs in conscious spontaneously hypertensive rats. J. Pharmacol. Exp. Ther., 273, 11621171.
  • CARPENE, C., COLLON, P., REMAURY, A., CORDI, A., HUDSON, A., NUTT, D. & LAFONTAN, M. (1995). Inhibition of amine oxidase activity by derivatives that recognize imidazoline 12 sites. J. Pharmacol. Exp. Ther., 272, 681688.
  • CHAN, S.L. (1998). Clonidine-displacing substance and its putative role in control of insulin secretion: a minireview. Gen. Pharmacol., 31, 525529.
  • CHAN, S.L., ATLAS, D., JAMES, R.F. & MORGAN, N.G. (1997). The effect of the putative endogenous imidazoline receptor ligand, clonidine-displacing substance, on insulin secretion from rat and human islets of Langerhans. Br. J. Pharmacol., 120, 926932.
  • CHAN, S.L., BROWN, C.A., SCARPELLO, K.E. & MORGAN, N.G. (1994). The imidazoline site involved in control of insulin secretion: characteristics that distinguish it from I1- and I2-sites. Br. J. Pharmacol, 112, 10651070.
  • CHAN, S.L., BROWN, C.A., SCARPELLO, K.E. & MORGAN, N.G. (1995). Pancreatic beta-cells express an imidazoline binding site that is distinct from I1 and I2 sites. Ann. N.Y. Acad. Sci., 763, 153156.
  • CHAN, S.L., DUNNE, M.J., STILLINGS, M.R. & MORGAN, N.G. (1991). The alpha 2-adrenoceptor antagonist efaroxan modulates K+ATP channels in insulin-secreting cells. Eur. J. Pharmacol, 204, 4148.
  • CHAN, S.L. & MORGAN, N.G. (1990). Stimulation of insulin secretion by efaroxan may involve interaction with potassium channels. Eur. J. Pharmacol, 176, 97101.
  • CHOI, D.W., KOH, J.Y. & PETERS, S. (1988). Pharmacology of glutamate neurotoxicity in cortical cell culture: attenuation by NMDA antagonists. J. Neurosci., 8, 185196.
  • COLUCCI, R., BLANDIZZI, C., CARIGNANI, D., PLACANICA, G., LAZZERI, G. & DEL TACCA, M. (1998). Effects of imidazoline derivatives on cholinergic motility in guinea-pig ileum: involvement of presynaptic alpha2-adrenoceptors or imidazoline receptors Naunyn Schmiedebergs Arch. Pharmacol., 357, 682691.
  • COUPRY, I., ATLAS, D., PODEVIN, R.A., UZIELLI, I. & PARINI, A. (1990). Imidazoline-guanidinium receptive site in renal proximal tubule: asymmetric distribution, regulation by cations and interaction with an endogenous clonidine displacing substance. J. Pharmacol. Exp. Ther., 252, 293299.
  • COURILLON-MALLET, A., LAUNAY, J.M., ROUCAYROL, A.M., CALLEBERT, J., EMOND, J.P., TABUTEAU, F. & CATTAN, D. (1995). Helicobacter pylori infection: physiopathologic implication of N alpha-methyl histamine. Gastroenterology, 108, 959966.
  • DALY, M.J. (1984). The classification of adrenoceptors and their effects on gastric acid secretion. Scand. J. Gastroenterol., 89 (Suppl.): 39.
  • DE VOS, H., BRICCA, G., DE KEYSER, J., DE BACKER, J.P., BOUSQUET, P. & VAUQUELIN, G. (1994). Imidazoline receptors, non-adrenergic idazoxan binding sites and alpha 2-adrenoceptors in the human central nervous system. Neuroscience, 59, 589598.
  • DE VOS, H., CONVENTS, A., DE KEYSER, J., DE BACKER, J.P., VAN MEGEN, I.J., EBINGER, G. & VAUQUELIN, G. (1991). Autoradiographic distribution of alpha 2 adrenoceptors, NAIBS, and 5- HT1A receptors in human brain using [3H]idazoxan and [3H]rauwolscine. Brain Res., 566, 1320.
  • DEGREGORIO-ROCASOLANO, N., OLMOS, G., GASULL, T., BORONAT, M.A., TRULLAS, R. & GARCIA-SEVILLA, J.A. (1999). Protection by imidazol(ine) compounds of L-glutamate neurotoxicity through NMDA receptor blockade. Ann. N.Y. Acad. Sci., 881, 452.
  • DEL TACCA, M., SOLDANI, G., BERNARDINI, C., MARTINOTTI, E. & IMPICCIATORE, M. (1982a). Pharmacological studies on the mechanisms underlying the inhibitory and excitatory effects of clonidine on gastric acid secretion. Eur. J. Pharmacol., 81, 255261.
  • DEL TACCA, M., SOLDANI, G., POLLONI, A., BERNARDINI, C. & MARTINOTTI, E. (1982b). The effect of pirenzepine on gastric acid secretion and gastrin release induced by bombesin and meal in the dog. Scand. J. Gastroenterol., 72 (Suppl.): 105110.
  • DIAMANT, S. & ATLAS, D. (1986). An endogenous brain substance, CDS (clonidine-displacing-substance), inhibits the twitch response of rat vas deferens. Biochem. Biophys. Res. Commun., 134, 184190.
  • DIETRICH, W.D., HALLEY, M., VALDES, I. & BUSTO, R. (1991). Interrelationships between increased vascular permeability and acute neuronal damage following temperature-controlled brain ischemia in rats. Acta Neuropathol., 81, 615625.
  • DONTENWILL, M., BRICCA, G., MOLINES, A., BOUSQUET, P. & BELCOURT, A. (1988). Production and characterization of anti-clonidine antibodies not cross-reacting with catecholamines. Eur. J. Pharmacol., 149, 249255.
  • DRIESSEN, A.J., SMID, E.J. & KONINGS, W.N. (1988). Transport of diamines by Enterococcus faecalis is mediated by an agmatine-putrescine antiporter. J. Bacteriol., 170, 45224527.
  • DUNNE, M.J., HARDING, E.A., JAGGAR, J.H., SQUIRES, P.E., LIANG, R., KANE, C., JAMES, R.F. & LONDON, N.J. (1995). Potassium channels, imidazolines, and insulin-secreting cells. Ann. N.Y. Acad. Sci., 763, 243261.
  • EL OMAR, E.M., PENMAN, I.D., ARDILL, J.E., CHITTAJALLU, R.S., HOWIE, C. & MCCOLL, K.E. (1995). Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology, 109, 681691.
  • ELLIOTT, K., KEST, B., MAN, A., KAO, B. & INTURRISI, C.E. (1995). N-methyl-D-aspartate (NMDA) receptors, mu and kappa opioid tolerance, and perspectives on new analgesic drug development. Neuropsychopharmacology, 13, 347356.
  • ERNSBERGER, P. (1999). The I1-imidazoline receptor and its cellular signaling pathways. Ann. N.Y. Acad. Sci., 881, 3553.
  • ERNSBERGER, P., FEINLAND, G., MEELEY, M.P. & REIS, D.J. (1990b). Characterization and visualization of clonidine-sensitive imidazole sites in rat kidney which recognize clonidine-displacing substance. Am. J. Hypertens., 3, 9097.
  • ERNSBERGER, P., GIULIANO, R., WILLETTE, R.N., GRANATA, A.R. & REIS, D.J. (1988b). Hypotensive action of clonidine analogues correlates with binding affinity at imidazole and not alpha-2-adrenergic receptors in the rostral ventrolateral medulla. J. Hypertens., 6 (Suppl.): S554S557.
  • ERNSBERGER, P., GIULIANO, R., WILLETTE, R.N. & REIS, D.J. (1990a). Role of imidazole receptors in the vasodepressor response to clonidine analogs in the rostral ventrolateral medulla. J. Pharmacol. Exp. Ther., 253, 408418.
  • ERNSBERGER, P., GRAVES, M.E., GRAFF, L.M., ZAKIEH, N., NGUYEN, P., COLLINS, L.A., WESTBROOKS, K.L. & JOHNSON, G.G. (1995). I1-imidazoline receptors. Definition, characterization, distribution, and transmembrane signaling. Ann. N.Y. Acad. Sci., 763, 2242.
  • ERNSBERGER, P., HAXHIU, M.A., GRAFF, L.M., COLLINS, L.A., DRESHAJ, I., GROVE, D.L., GRAVES, M.E., SCHÄFER, S.G. & CHRISTEN, M.O. (1994). A novel mechanism of action for hypertension control: moxonidine as a selective I1-imidazoline agonist. Cardiovasc. Drugs Ther., 8 (Suppl.1): 2741.
  • ERNSBERGER, P., MEELEY, M.P., MANN, J.J. & REIS, D.J. (1987). Clonidine binds to imidazole binding sites as well as alpha 2- adrenoceptors in the ventrolateral medulla. Eur. J. Pharmacol., 134, 113.
  • ERNSBERGER, P., MEELEY, M.P. & REIS, D.J. (1988a). An endogenous substance with clonidine-like properties: selective binding to imidazole sites in the ventrolateral medulla. Brain Res., 441, 309318.
  • ERNSBERGER, P., WESTBROOKS, K.L., CHRISTEN, M.O. & SCHÄFER, S.G. (1992). A second generation of centrally acting antihypertensive agents on putative I1-imidazoline receptors. J. Cardiovasc. Pharmacol., 20 (Suppl.4): S1S10.
  • ESCRIBA, P.V., ALEMANY, R., SASTRE, M., OLMOS, G., OZAITA, A. & GARCIA-SEVILLA, J.A. (1996). Pharmacological modulation of immunoreactive imidazoline receptor proteins in rat brain: relationship with non-adrenoceptor [3H]-idazoxan binding sites. Br. J. Pharmacol., 118, 20292036.
  • ESCRIBA, P.V., OZAITA, A. & GARCIA-SEVILLA, J.A. (1999). Pharmacologic characterization of imidazoline receptor proteins identified by immunologic techniques and other methods. Ann. N.Y. Acad. Sci., 881, 825.
  • EVANS, R.G. & HAYNES, J.M. (1995). Alpha 2 adrenoceptor- and Imidazoline-prefering binding sites in the dog kidney. Ann. N.Y. Acad. Sci., 763, 357360.
  • FAIRBANKS, C.A. & WILCOX, G.L. (1999). Moxonidine, a selective alpha2-adrenergic and imidazoline receptor agonist, produces spinal antinociception in mice. J. Pharmacol. Exp. Ther., 290, 403412.
  • FELSEN, D., ERNSBERGER, P., MEELEY, M.P. & REIS, D.J. (1987). Clonidine displacing substance is biologically active on smooth muscle. Eur. J. Pharmacol., 142, 453455.
  • FENG, Y., HALARIS, A.E. & PILETZ, J.E. (1997). Determination of agmatine in brain and plasma using high-performance liquid chromatography with fluorescence detection. J. Chromatogr. B Biomed. Sci. Appl., 691, 277286.
  • FINCH, L., BUCKINGHAM, R.E., MOORE, R.A. & BUCHER, T.J. (1975). Evidence for a central alpha-sympathomimetic action of clonidine in the rat. J. Pharm. Pharmacol., 27, 181186.
  • FRANK, E. (1927). Über eine synthetische Substanz (Synthalin) mit insulinartiger Wirkung. Die Naturwissenschaften, 9, 213215.
  • FUDER, H. & SCHWARZ, P. (1993). Desensitization of inhibitory prejunctional alpha 2-adrenoceptors and putative imidazoline receptors on rabbit heart sympathetic nerves. Naunyn Schmiedebergs Arch. Pharmacol., 348, 127133.
  • GALEA, E., REGUNATHAN, S., ELIOPOULOS, V., FEINSTEIN, D.L. & REIS, D.J. (1996). Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine. Biochem. J., 316, 247249.
  • GAO, Y., GUMUSEL, B., KOVES, G., PRASAD, A., HAO, Q., HYMAN, A. & LIPPTON, H. (1995). Agmatine: a novel endogenous vasodilator substance. Life Sci., 57, L83L86.
  • GARCIA-SEVILLA, J.A., ESCRIBA, P.V., BUSQUETS, X., WALZER, C. & GUIMON, J. (1996). Platelet imidazoline receptors and regulatory G proteins in patients with major depression. Neuroreport, 8, 169172.
  • GARCIA-SEVILLA, J.A., ESCRIBA, P.V. & GUIMON, J. (1999). Imidazoline receptors and human brain disorders. Ann. N.Y. Acad. Sci., 881, 392409.
  • GARCIA-SEVILLA, J.A., ESCRIBA, P.V., OZAITA, A., WALZER, C. & GUIMON, J. (1998a). Density of imidazoline receptors in platelets of euthymic patients with bipolar affective disorder and in brains of lithium-treated rats. Biol. Psychiatry, 43, 616618.
  • GARCIA-SEVILLA, J.A., ESCRIBA, P.V., WALZER, C., BOURAS, C. & GUIMON, J. (1998b). Imidazoline receptor proteins in brains of patients with Alzheimer's disease. Neurosci. Lett., 247, 9598.
  • GILAD, G.M., GILAD, V.H. & RABEY, J.M. (1996c). Arginine and ornithine decarboxylation in rodent brain: coincidental changes during development and after ischemia. Neurosci. Lett., 216, 3336.
  • GILAD, G.M., SALAME, K., RABEY, J.M. & GILAD, V.H. (1996b). Agmatine treatment is neuroprotective in rodent brain injury models. Life Sci., 58, L-6.
  • GILAD, G.M., WOLLAM, Y., IAINA, A., RABEY, J.M., CHERNIHOVSKY, T. & GILAD, V.H. (1996a). Metabolism of agmatine into urea but not into nitric oxide in rat brain. Neuroreport, 7, 17301732.
  • GLAVIN, G.B., CARLISLE, M.A. & SMYTH, D.D. (1995). Agmatine, an endogenous imidazoline receptor agonist, increases gastric secretion and worsens experimental gastric mucosal injury in rats. J. Pharmacol. Exp. Ther., 274, 741744.
  • GLAVIN, G.B. & SMYTH, D.D. (1995a). Moxonidine decreases gastric secretion and gastric mucosal injury in rats. Ann. N.Y. Acad. Sci., 763, 433435.
  • GLAVIN, G.B. & SMYTH, D.D. (1995b). Effects of the selective I1 imidazoline receptor agonist, moxonidine, on gastric secretion and gastric mucosal injury in rats. Br. J. Pharmacol., 114, 751754.
  • GOMEZ, R.E., ERNSBERGER, P., FEINLAND, G. & REIS, D.J. (1991). Rilmenidine lowers arterial pressure via imidazole receptors in brainstem C1 area. Eur. J. Pharmacol., 195, 181191.
  • GONZALEZ, C., REGUNATHAN, S., REIS, D.J. & ESTRADA, C. (1996). Agmatine, an endogenous modulator of noradrenergic neurotransmission in the rat tail artery. Br. J. Pharmacol., 119, 677684.
  • GOSSOP, M. (1988). Clonidine and the treatment of the opiate withdrawal syndrome. Drug Alcohol Depend., 21, 253259.
  • GÖTHERT, M., BRÜSS, M., BÖNISCH, H. & MOLDERINGS, G.J. (1999). Presynaptic imidazoline receptors. New developments in characterization and classification. Ann. N.Y. Acad. Sci., 881, 171184.
  • GÖTHERT, M. & MOLDERINGS, G.J. (1991). Involvement of presynaptic imidazoline receptors in the alpha 2- adrenoceptor-independent inhibition of noradrenaline release by imidazoline derivatives. Naunyn Schmiedebergs Arch. Pharmacol., 343, 271282.
  • GÖTHERT, M., MOLDERINGS, G.J., FINK, K. & SCHLICKER, E. (1995). Alpha 2-adrenoceptor-independent inhibition by imidazolines and guanidines of noradrenaline release from peripheral, but not central noradrenergic neurons. Ann. N.Y. Acad. Sci., 763, 405419.
  • GRIGG, M., MUSGRAVE, I.F. & BARROW, C.J. (1998). Isolation and partial structure determination of a clonidine-displacing substance from bovine lung and brain. J. Auton. Nerv. Syst., 72, 8693.
  • GUSTAFSON, I., WESTERBERG, E. & WIELOCH, T. (1990). Protection against ischemia-induced neuronal damage by the alpha 2- adrenoceptor antagonist idazoxan: influence of time of administration and possible mechanisms of action. J. Cereb. Blood Flow Metab., 10, 885894.
  • HÄUSER, W. & DOMINIAK, P. (1995). Effects of agmatine on catecholamine release and blood pressure of spontaneously hypertensive rats. A possible role for imidazoline receptors Pharm. Pharmacol. Lett., 5, 8789.
  • HÄUSER, W., GÜTTING, J., NGUYEN, T. & DOMINIAK, P. (1995). Influence of imidazolines on catecholamine release in pithed spontaneously hypertensive rats. Ann. N.Y. Acad. Sci., 763, 573579.
  • HAEUSLER, G. (1974a). Proceedings: Sympathetic nerve activity after noradrenaline depletion and its alteration by clonidine. Naunyn Schmiedebergs Arch. Pharmacol., 282 (Suppl.): R29.
  • HAEUSLER, G. (1974b). Clonidine-induced inhibition of sympathetic nerve activity: no indication for a central presynaptic or an indirect sympathomimetic mode of action. Naunyn Schmiedebergs Arch. Pharmacol., 286, 107111.
  • HALARIS, A., ZHU, H., FENG, Y. & PILETZ, J.E. (1999). Plasma agmatine and platelet imidazoline receptors in depression. Ann. N.Y. Acad. Sci., 881, 445451.
  • HALBREICH, U., PILETZ, J.E., CARSON, S., HALARIS, A. & ROJANSKY, N. (1993). Increased imidazoline and alpha 2 adrenergic binding in platelets of women with dysphoric premenstrual syndromes. Biol. Psychiatry, 34, 676686.
  • HAMILTON, C.A. (1992a). Adrenergic and nonadrenergic effects of imidazoline and related antihypertensive drugs in the brain and periphery. Am. J. Hypertens., 5, 58S63S.
  • HAMILTON, C.A. (1992b). The role of imidazoline receptors in blood pressure regulation. Pharmacol. Ther., 54, 231248.
  • HAMILTON, C.A., YAKUBU, M.A., HOWIE, C.A. & REID, J.L. (1992). Do centrally-acting antihypertensive drugs act at non-adrenergic as well as alpha-2 adrenoceptor sites Clin. Exp. Hypertens. [A], 14, 815835.
  • HAXHIU, M.A., DRESHAJ, I., SCHÄFER, S.G. & ERNSBERGER, P. (1994). Selective antihypertensive action of moxonidine is mediated mainly by I1-imidazoline receptors in the rostral ventrolateral medulla. J. Cardiovasc. Pharmacol., 24 (Suppl.1): S1S8.
  • HEAD, G.A., CHAN, C.K. & GODWIN, S.J. (1997). Central cardiovascular actions of agmatine, a putative clonidine- displacing substance, in conscious rabbits. Neurochem. Int., 30, 3745.
  • HEIN, L. (2001). Transgenic models of alpha 2-adrenergic receptor subtype function. Rev. Physiol. Biochem. Pharmacol., 142, 161185.
  • HEIN, L., LIMBIRD, L.E., EGLEN, R.M. & KOBILKA, B.K. (1999). Gene substitution/knockout to delineate the role of alpha 2- adrenoceptor subtypes in mediating central effects of catecholamines and imidazolines. Ann. N.Y. Acad. Sci., 881, 265271.
  • HENSLEY, M.L., MEELEY, M.P., MCCAULEY, P.M., ERNSBERGER, P. & REIS, D.J. (1989). Clonidine-displacing substance is present in peripheral tissues of the rat. Am. J. Hypertens., 2, 917919.
  • HIEBLE, J.P., DEMARINIS, R.M., FOWLER, P.J. & MATTHEWS, W.D. (1986). Selective alpha-2 adrenoceptor blockade by SK&F 86466: in vitro characterization of receptor selectivity. J. Pharmacol. Exp. Ther., 236, 9096.
  • HIEBLE, J.P. & RUFFOLO, R.R., JR. (1992). Imidazoline receptors: historical perspective. Fundam. Clin. Pharmacol., 6 (Suppl.1): 7S13S.
  • HILLAIRE-BUYS, D., GROSS, R., BLAYAC, J.P., RIBES, G. & LOUBATIERES-MARIANI, M.M. (1985). Effects of alpha-adrenoceptor agonists and antagonists on insulin secreting cells and pancreatic blood vessels: comparative study. Eur. J. Pharmacol., 117, 253257.
  • HOLT, A. & BAKER, G.B. (1995). Metabolism of agmatine (clonidine-displacing substance) by diamine oxidase and the possible implications for studies of imidazoline receptors. Prog. Brain Res., 106, 187197.
  • HORVATH, G., KEKESI, G., DOBOS, I., SZIKSZAY, M., KLIMSCHA, W. & BENEDEK, G. (1999). Effect of intrathecal agmatine on inflammation-induced thermal hyperalgesia in rats. Eur. J. Pharmacol., 368, 197204.
  • HOUI, N., KAMISAKI, Y. & ITOH, T. (1987). Effects of histamine H2 receptor antagonists on acid secretion stimulated by imidazoline derivatives in isolated parietal cells. Eur. J. Pharmacol., 144, 6776.
  • HUNTER, K.J., STROBOS, C.A. & FAIRLAMB, A.H. (1991). Inhibition of polyamine biosynthesis in Crithidia fasciculata by D,L-alpha-difluoromethylornithine and D,L-alpha-difluoromethylarginine. Mol. Biochem. Parasitol., 46, 3543.
  • ISHIDA-TAKAHASHI, A., HORIE, M., TSUURA, Y., ISHIDA, H., AI, T. & SASAYAMA, S. (1996). Block of pancreatic ATP-sensitive K+ channels and insulinotrophic action by the antiarrhythmic agent, cibenzoline. Br. J. Pharmacol., 117, 17491755.
  • ISHIKAWA, T., MISONOU, T., IKENO, M., SATO, K. & SAKAMAKI, T. (1995). N omega-hydroxyagmatine: a novel substance causing endothelium- dependent vasorelaxation. Biochem. Biophys. Res. Commun., 214, 145151.
  • JONAS, J.C., PLANT, T.D. & HENQUIN, J.C. (1992). Imidazoline antagonists of alpha 2-adrenoceptors increase insulin release in vitro by inhibiting ATP-sensitive K+ channels in pancreatic beta-cells. Br. J. Pharmacol., 107, 814.
  • JONES, B.E. & YANG, T.Z. (1985). The efferent projections from the reticular formation and the locus coeruleus studied by anterograde and retrograde axonal transport in the rat. J. Comp Neurol., 242, 5692.
  • JURKIEWICZ, N.H., GARCEZ DO, C.L., HIRATA, H., DA COSTA, S.W. & JURKIEWICZ, A. (1996). Functional properties of agmatine in rat vas deferens. Eur. J. Pharmacol., 307, 299304.
  • KAMISAKI, Y., ISHIKAWA, T., TAKAO, Y., OMODANI, H., KUNO, N. & ITOH, T. (1990). Binding of [3H]p-aminoclonidine to two sites, alpha 2-adrenoceptors and imidazoline binding sites: distribution of imidazoline binding sites in rat brain. Brain Res., 514, 1521.
  • KASHIWAGI, K., KOBAYASHI, H. & IGARASHI, K. (1986). Apparently unidirectional polyamine transport by proton motive force in polyamine-deficient Escherichia coli. J. Bacteriol., 165, 972977.
  • KING, P.R., GUNDLACH, A.L. & LOUIS, W.J. (1995). Quantitative autoradiographic localization in rat brain of alpha 2-adrenergic and non-adrenergic I-receptor binding sites labelled by [3H]rilmenidine. Brain Res., 675, 264278.
  • KOBINGER, W. & PICHLER, L. (1976). Centrally induced reduction in sympathetic tone-a postsynaptic alpha- adrenoceptor-stimulating action of imidazolines. Eur. J. Pharmacol., 40, 311320.
  • KOLESNIKOV, Y., JAIN, S. & PASTERNAK, G.W. (1996). Modulation of opioid analgesia by agmatine. Eur. J. Pharmacol., 296, 1722.
  • KOSSEL, A. (1910). Über das Agmatin. Hoppe Seylers. Z. Physiol. Chem., 66, 257261.
  • LAMBERTI, C., IPPONI, A., BARTOLINI, A., SCHUNACK, W. & MALMBERG-AIELLO, P. (1998). Antidepressant-like effects of endogenous histamine and of two histamine H1 receptor agonists in the mouse forced swim test. Br. J. Pharmacol., 123, 13311336.
  • LANGER, J., PANTEN, U. & ZIELMANN, S. (1983). Effects of alpha-adrenoceptor antagonists on clonidine-induced inhibition of insulin secretion by isolated pancreatic islets. Br. J. Pharmacol., 79, 415420.
  • LANGER, S.Z. & HICKS, P.E. (1984). Alpha-adrenoreceptor subtypes in blood vessels: physiology and pharmacology. J. Cardiovasc. Pharmacol., 6 (Suppl 4): S547S558.
  • LEVEQUE, J., BURTIN, F., CATROS-QUEMENER, V., HAVOUIS, R. & MOULINOUX, J.P. (1998). The gastrointestinal polyamine source depletion enhances DFMO induced polyamine depletion in MCF-7 human breast cancer cells in vivo. Anticancer Res., 18, 26632668.
  • LI, G., REGUNATHAN, S., BARROW, C.J., ESHRAGHI, J., COOPER, R. & REIS, D.J. (1994a). Agmatine: an endogenous clonidine-displacing substance in the brain. Science, 263, 966969.
  • LI, G., REGUNATHAN, S. & REIS, D.J. (1995). Agmatine is synthesized by a mitochondrial arginine decarboxylase in rat brain. Ann. N.Y. Acad. Sci., 763, 325329.
  • LI, P., PENNER, S.B. & SMYTH, D.D. (1994b). Attenuated renal response to moxonidine and rilmenidine in one kidney- one clip hypertensive rats. Br. J. Pharmacol., 112, 200206.
  • LIKUNGU, J., MOLDERINGS, G.J. & GÖTHERT, M. (1996). Presynaptic imidazoline receptors and alpha 2-adrenoceptors in the human heart: discrimination by clonidine and moxonidine. Naunyn Schmiedebergs Arch. Pharmacol., 354, 689692.
  • LIMON, I., COUPRY, I., LANIER, S.M. & PARINI, A. (1992). Purification and characterization of mitochondrial imidazoline- guanidinium receptive site from rabbit kidney. J. Biol. Chem., 267, 2164521649.
  • LIU, L. & COUPAR, I.M. (1997). Involvement of alpha-2 adrenoceptors in the effects of moxonidine on intestinal motility and fluid transport. J. Pharmacol. Exp. Ther., 283, 13671374.
  • LORING, R.H. (1990). Agmatine acts as an antagonist of neuronal nicotinic receptors. Br. J. Pharmacol., 99, 207211.
  • LORTIE, M.J., NOVOTNY, W.F., PETERSON, O.W., VALLON, V., MALVEY, K., MENDONCA, M., SATRIANO, J., INSEL, P., THOMSON, S.C. & BLANTZ, R.C. (1996). Agmatine, a bioactive metabolite of arginine. Production, degradation, and functional effects in the kidney of the rat. J. Clin. Invest., 97, 413420.
  • LYSKO, P.G., COX, J.A., VIGANO, M.A. & HENNEBERRY, R.C. (1989). Excitatory amino acid neurotoxicity at the N-methyl-D-aspartate receptor in cultured neurons: pharmacological characterization. Brain Res., 499, 258266.
  • MACMILLAN, L.B., HEIN, L., SMITH, M.S., PIASCIK, M.T. & LIMBIRD, L.E. (1996). Central hypotensive effects of the alpha2a-adrenergic receptor subtype. Science, 273, 801803.
  • MAIESE, K., PEK, L., BERGER, S.B. & REIS, D.J. (1992). Reduction in focal cerebral ischemia by agents acting at imidazole receptors. J. Cereb. Blood Flow Metab., 12, 5363.
  • MALLARD, N.J., HUDSON, A.L. & NUTT, D.J. (1992). Characterization and autoradiographical localization of non- adrenoceptor idazoxan binding sites in the rat brain. Br. J. Pharmacol., 106, 10191027.
  • MAZE, M., SEGAL, I.S. & BLOOR, B.C. (1988). Clonidine and other alpha2 adrenergic agonists: strategies for the rational use of these novel anesthetic agents. J. Clin. Anesth., 1, 146157.
  • MEDGETT, I.C. & MCCULLOCH, M.W. (1979). Effects of clonidine, guanfacine and three imidazolidine derivatives related to clonidine on blood pressure, heart rate and gastric acid secretion in the anaesthetized rat. Arch. Int. Pharmacodyn. Ther., 240, 158168.
  • MEELEY, M.P., ERNSBERGER, P.R., GRANATA, A.R. & REIS, D.J. (1986). An endogenous clonidine-displacing substance from bovine brain: receptor binding and hypotensive actions in the ventrolateral medulla. Life Sci., 38, 11191126.
  • MEELEY, M.P., ERNSBERGER, P., MCCAULEY, P.M. & REIS, D.J. (1988a). Clonidine-specific antibodies as models for imidazole and alpha 2-adrenergic receptor binding sites: implications for the structure of clonidine-displacing substance. J. Hypertens., 6 (Suppl): S490S493.
  • MEELEY, M.P., HENSLEY, M.L., ERNSBERGER, P., FELSEN, D. & REIS, D.J. (1992). Evidence for a bioactive clonidine-displacing substance in peripheral tissues and serum. Biochem. Pharmacol., 44, 733740.
  • MEELEY, M.P., TOWLE, A.C., ERNSBERGER, P. & REIS, D.J. (1988b). A specific antiserum recognizes clonidine-displacing substance: implications for the structure of the brain's own clonidine. Neurosci. Lett., 84, 8490.
  • MERCENIER, A., SIMON, J.P., HAAS, D. & STALON, V. (1980). Catabolism of L-arginine by Pseudomonas aeruginosa. J. Gen. Microbiol., 116, 381389.
  • MESHUL, C.K., SEIL, F.J. & HERNDON, R.M. (1987). Astrocytes play a role in regulation of synaptic density. Brain Res., 402, 139145.
  • MICHEL, M.C., BRODDE, O.E., SCHNEPEL, B., BEHRENDT, J., TSCHADA, R., MOTULSKY, H.J. & INSEL, P.A. (1989). [3H]idazoxan and some other alpha 2-adrenergic drugs also bind with high affinity to a nonadrenergic site. Mol. Pharmacol., 35, 324330.
  • MICHEL, M.C. & ERNSBERGER, P. (1992). Keeping an eye on the I site: imidazoline-preferring receptors. Trends Pharmacol. Sci., 13, 369370.
  • MICHEL, M.C. & INSEL, P.A. (1989). Are there multiple imidazoline binding sites Trends Pharmacol. Sci., 10, 342344.
  • MICHEL, M.C. & RUMP, L.C. (1996). alpha-Adrenergic regulation of human renal function. Fundam. Clin. Pharmacol., 10, 493503.
  • MOLDERINGS, G.J., BÖNISCH, M., GÖTHERT. & BRÜSS, H. (2001). Agmatine and putrescine uptake in the human glioma cell line SK-MG-1. Naunyn Schmiedebergs Arch. Pharmacol., 363, 671679.
  • MOLDERINGS, G.J., BURIAN, M., HOMANN, J., NILIUS, M. & GÖTHERT, M. (1999d). Potential relevance of agmatine as a virulence factor of Helicobacter pylori. Dig. Dis. Sci., 44, 23972404.
  • MOLDERINGS, G.J., BURIAN, M., MENZEL, S., DONECKER, K., HOMANN, J., NILIUS, M. & GÖTHERT, M. (1999c). Imidazoline recognition sites and stomach function. Ann. N.Y. Acad. Sci., 881, 332343.
  • MOLDERINGS, G.J., DONECKER, K., BURIAN, M., SIMON, W.A., SCHRODER, D.W. & GÖTHERT, M. (1998b). Characterization of I2 imidazoline and sigma binding sites in the rat and human stomach. J. Pharmacol. Exp. Ther., 285, 170177.
  • MOLDERINGS, G.J., DONECKER, K. & GÖTHERT, M. (1995). Characterization of non-adrenergic [3H]clonidine binding sites in rat stomach: high affinity of imidazolines, guanidines and sigma ligands. Naunyn Schmiedebergs Arch. Pharmacol., 351, 561564.
  • MOLDERINGS, G.J. & GÖTHERT, M. (1995). Inhibitory presynaptic imidazoline receptors on sympathetic nerves in the rabbit aorta differ from I1- and I2-imidazoline binding sites. Naunyn Schmiedebergs Arch. Pharmacol., 351, 507516.
  • MOLDERINGS, G.J., GÖTHERT, M., HOMANN, J. & NILIUS, M. (1998a). Potential relevance of agmatine for the pathogenesis of gastric mucosal lesions. Naunyn Schmiedebergs Arch. Pharmacol., 357 (Suppl): R166.
  • MOLDERINGS, G.J., HENTRICH, F. & GÖTHERT, M. (1991). Pharmacological characterization of the imidazoline receptor which mediates inhibition of noradrenaline release in the rabbit pulmonary artery. Naunyn Schmiedebergs Arch. Pharmacol., 344, 630638.
  • MOLDERINGS, G.J., LIKUNGU, J. & GÖTHERT, M. (1999b). Presynaptic cannabinoid and imidazoline receptors in the human heart and their potential relationship. Naunyn Schmiedebergs Arch. Pharmacol., 360, 157164.
  • MOLDERINGS, G.J., LIKUNGU, J., JAKSCHIK, J. & GÖTHERT, M. (1997). Presynaptic imidazoline receptors and non-adrenoceptor [3H]-idazoxan binding sites in human cardiovascular tissues. Br. J. Pharmacol., 122, 4350.
  • MOLDERINGS, G.J., MENZEL, S. & GÖTHERT, M. (1999a). Imidazoline derivatives and agmatine induce histamine release from the rat stomach. Naunyn Schmiedebergs Arch. Pharmacol., 360, 711714.
  • MOLDERINGS, G.J., MENZEL, S., KATHMANN, M., SCHLICKER, E. & GÖTHERT, M. (2000). Dual interaction of agmatine with the rat alpha(2D)-adrenoceptor: competitive antagonism and allosteric activation. Br. J. Pharmacol., 130, 17061712.
  • MOLDERINGS, G.J., MOURA, D., FINK, K., BÖNISCH, H. & GÖTHERT, M. (1993). Binding of [3H]clonidine to I1-imidazoline sites in bovine adrenal medullary membranes. Naunyn Schmiedebergs Arch. Pharmacol., 348, 7076.
  • MOLDERINGS, G.J., SCHMIDT, K., BÖNISCH, H. & GÖTHERT, M. (1996). Inhibition of 5-HT3 receptor function by imidazolines in mouse neuroblastoma cells: potential involvement of sigma 2 binding sites. Naunyn Schmiedebergs Arch. Pharmacol., 354, 245252.
  • MORGAN, N.G., CHAN, S.L., BROWN, C.A. & TSOLI, E. (1995). Characterization of the imidazoline binding site involved in regulation of insulin secretion. Ann. N.Y. Acad. Sci., 763, 361373.
  • MORGAN, N.G., CHAN, S.L., MOURTADA, M., MONKS, L.K. & RAMSDEN, C.A. (1999). Imidazolines and pancreatic hormone secretion. Ann. N.Y. Acad. Sci., 881, 217228.
  • MUNK, S.A., LAI, R.K., BURKE, J.E., ARASASINGHAM, P.N., KHARLAMB, A.B., MANLAPAZ, C.A., PADILLO, E.U., WIJONO, M.K., HASSON, D.W., WHEELER, L.A. & GARST, M.E. (1996). Synthesis and pharmacologic evaluation of 2-endo-amino-3-exo-isopropylbicyclo[2.2.1]heptane: a potent imidazoline 1 receptor specific agent. J. Med. Chem., 39, 11931195.
  • NESTLER, E.J., BERHOW, M.T. & BRODKIN, E.S. (1996). Molecular mechanisms of drug addiction: adaptations in signal transduction pathways. Mol. Psychiatry, 1, 190199.
  • NICHOLAS, A.P., HOKFELT, T. & PIERIBONE, V.A. (1996). The distribution and significance of CNS adrenoceptors examined with in situ hybridization. Trends Pharmacol. Sci., 17, 245255.
  • NICHOLAS, A.P., PIERIBONE, V. & HOKFELT, T. (1993). Distributions of mRNAs for alpha-2 adrenergic receptor subtypes in rat brain: an in situ hybridization study. J. Comp. Neurol., 328, 575594.
  • OHARA-IMAIZUMI, M. & KUMAKURA, K. (1992). Effects of imidazole compounds on catecholamine release in adrenal chromaffin cells. Cell. Mol. Neurobiol., 12, 273283.
  • OLMOS, G., ALEMANY, R., ESCRIBA, P.V. & GARCIA-SEVILLA, J.A. (1994). The effects of chronic imidazoline drug treatment on glial fibrillary acidic protein concentrations in rat brain. Br. J. Pharmacol., 111, 9971002.
  • OLMOS, G., DEGREGORIO-ROCASOLANO, N., PAZ, R.M., GASULL, T., ASSUMPCIO, B.M., TRULLAS, R., VILLARROEL, A., LERMA, J. & GARCIA-SEVILLA, J.A. (1999). Protection by imidazol(ine) drugs and agmatine of glutamate-induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor. Br. J. Pharmacol., 127, 13171326.
  • OLMOS, G., GABILONDO, A.M., MIRALLES, A., ESCRIBA, P.V. & GARCIA-SEVILLA, J.A. (1993). Chronic treatment with the monoamine oxidase inhibitors clorgyline and pargyline down-regulates non-adrenoceptor [3H]-idazoxan binding sites in the rat brain. Br. J. Pharmacol., 108, 597603.
  • OLMOS, G., RIBERA, J. & GARCIA-SEVILLA, J.A. (1996). Imidazoli(di)ne compounds interact with the phencyclidine site of NMDA receptors in the rat brain. Eur. J. Pharmacol., 310, 273276.
  • OTAKE, K., RUGGIERO, D.A., REGUNATHAN, S., WANG, H., MILNER, T.A. & REIS, D.J. (1998). Regional localization of agmatine in the rat brain: an immunocytochemical study. Brain Res., 787, 114.
  • PANAGIOTIDIS, C.A., BLACKBURN, S., LOW, K.B. & CANELLAKIS, E.S. (1987). Biosynthesis of polyamines in ornithine decarboxylase, arginine decarboxylase, and agmatine ureohydrolase deletion mutants of Escherichia coli strain K-12. Proc. Natl. Acad. Sci. U.S.A., 84, 44234427.
  • PARKER, C.A., HUDSON, A.L., NUTT, D.J., DILLON, M.P., EGLEN, R.M., CHAN, S.L., MORGAN, N.G. & CROSBY, J. (1999a). Extraction of active clonidine-displacing substance from bovine lung and comparison with clonidine-displacing substance extracted from other tissues. Eur. J. Pharmacol., 378, 213221.
  • PARKER, C.A., HUDSON, A.L., NUTT, D.J., DILLON, M.P., EGLEN, R.M. & CROSBY, J. (1999b). Comparison of crude methanolic CDS extracts from various tissues. Ann. N.Y. Acad. Sci., 881, 9296.
  • PEGG, A.E. & MCCANN, P.P. (1982). Polyamine metabolism and function. Am. J. Physiol., 243, C212C221.
  • PENNER, S.B. & SMYTH, D.D. (1996). Natriuresis following central and peripheral administration of agmatine in the rat. Pharmacology, 53, 160169.
  • PERSSON, L., HOLM, I. & HEBY, O. (1986). Translational regulation of ornithine decarboxylase by polyamines. FEBS Lett., 205, 175178.
  • PETERSON, W.L. (1996). Gastrin and acid in relation to Helicobacter pylori. Aliment. Pharmacol. Ther., 10 (Suppl 1): 97102.
  • PILETZ, J.E., CHIKKALA, D.N. & ERNSBERGER, P. (1995). Comparison of the properties of agmatine and endogenous clonidine- displacing substance at imidazoline and alpha-2 adrenergic receptors. J. Pharmacol. Exp. Ther., 272, 581587.
  • PILETZ, J.E. & HALARIS, A. (1995). Involvement of I1-imidazoline receptors in mood disorders. Ann. N.Y. Acad. Sci., 763, 510519.
  • PILETZ, J.E., HALARIS, A., NELSON, J., QU, Y. & BARI, M. (1996c). Platelet I1-imidazoline binding sites are elevated in depression but not generalized anxiety disorder. J. Psychiatr. Res., 30, 147168.
  • PILETZ, J.E., HALARIS, A.E., CHIKKALA, D. & QU, Y. (1996b). Platelet I1-imidazoline binding sites are decreased by two dissimilar antidepressant agents in depressed patients. J. Psychiatr. Res., 30, 169184.
  • PILETZ, J.E., IVANOV, T.R., SHARP, J.D., ERNSBERGER, P., CHANG, C.H., PICKARD, R.T., GOLD, G., ROTH, B., ZHU, H., JONES, J.C., BALDWIN, J. & REIS, D.J. (2000). Imidazoline receptor antisera-selected (IRAS) cDNA: cloning and characterization. DNA Cell. Biol., 19, 319329.
  • PILETZ, J.E., ZHU, H. & CHIKKALA, D.N. (1996a). Comparison of ligand binding affinities at human I1-imidazoline binding sites and the high affinity state of alpha-2 adrenoceptor subtypes. J. Pharmacol. Exp. Ther., 279, 694702.
  • PINTHONG, D., HUSSAIN, J.F., KENDALL, D.A. & WILSON, V.G. (1995b). Comparison of the interaction of agmatine and crude methanolic extracts of bovine lung and brain with alpha 2-adrenoceptor binding sites. Br. J. Pharmacol., 115, 689695.
  • PINTHONG, D., WRIGHT, I.K., HANMER, C., MILLNS, P., MASON, R., KENDALL, D.A. & WILSON, V.G. (1995a). Agmatine recognizes alpha 2-adrenoceptor binding sites but neither activates nor inhibits alpha 2-adrenoceptors. Naunyn Schmiedebergs Arch. Pharmacol., 351, 1016.
  • PLANT, T.D. & HENQUIN, J.C. (1990). Phentolamine and yohimbine inhibit ATP-sensitive K+ channels in mouse pancreatic beta-cells. Br. J. Pharmacol., 101, 115120.
  • PURCELL, W.M., DOYLE, K.M., BAGGA, L. & DERKS, M. (1994). Histamine release from mast cells by polyamines: an NMDA receptor- mediated event Biochem. Soc. Trans., 22, 398S.
  • QUAN, D.B., WANDRES, D.L. & SCHROEDER, D.J. (1993). Clonidine in pain management. Ann. Pharmacother., 27, 313315.
  • QUIK, M. (1985). Inhibition of nicotinic receptor mediated ion fluxes in rat sympathetic ganglia by BGT II-S1 a potent phospholipase. Brain Res., 325, 7988.
  • RAASCH, W., CHUN, K.R.J., DENDORFER, A. & DOMINIAK, P. (2000). Positive inotropic effects of imidazoline derivatives are not mediated via imidazoline binding sites but alpha1-adrenergic receptors. Jpn. J. Pharmacol., 84, 16.
  • RAASCH, W., LIST, B., HÄUSER, W., SCHÄFER, U. & DOMINIAK, P. (1999). Presynaptic release of noradrenaline is mediated not only through α2-adrenoceptors but also through imidazoline binding sites. Dtsch. Med. Wschr., 124, S114.
  • RAASCH, W., MUHLE, H. & DOMINIAK, P. (1996). Monoamine oxidase (MAO) is inhibited by imidazoline binding site I2 specific ligands in vitro. Pharm. Pharmacol. Lett., 6, 4245.
  • RAASCH, W., MUHLE, H. & DOMINIAK, P. (1999). Modulation of MAO activity by imidazoline and guanidine derivatives. Ann. N.Y. Acad. Sci., 881, 313331.
  • RAASCH, W., REGUNATHAN, S., LI, G. & REIS, D.J. (1995a). Agmatine, the bacterial amine, is widely distributed in mammalian tissues. Life Sci., 56, 23192330.
  • RAASCH, W., REGUNATHAN, S., LI, G. & REIS, D.J. (1995b). Agmatine is widely and unequally distributed in rat organs. Ann. N.Y. Acad. Sci., 763, 330334.
  • RADDATZ, R. & LANIER, S.M. (1997). Relationship between imidazoline/guanidinium receptive sites and monoamine oxidase A and B. Neurochem. Int., 30, 109117.
  • RADDATZ, R., PARINI, A. & LANIER, S.M. (1995). Imidazoline/guanidinium binding domains on monoamine oxidases. Relationship to subtypes of imidazoline-binding proteins and tissue-specific interaction of imidazoline ligands with monoamine oxidase B. J. Biol. Chem., 270, 2796127968.
  • RADDATZ, R., PARINI, A. & LANIER, S.M. (1997). Localization of the imidazoline binding domain on monoamine oxidase B. Mol. Pharmacol., 52, 549553.
  • RADDATZ, R., SAVIC, S.L., BAKTHAVACHALAM, V., LESNICK, J., JASPER, J.R., MCGRATH, C.R., PARINI, A. & LANIER, S.M. (2000). Imidazoline-binding domains on monoamine oxidase B and subpopulations of enzyme. J. Pharmacol. Exp. Ther., 292, 11351145.
  • RADDATZ, R., SAVIC, S.L. & LANIER, S.M. (1999). Imidazoline binding domains on MAO-B. Localization and accessibility. Ann. N.Y. Acad. Sci., 881, 2631.
  • RAMAKRISHNA, S. & ADIGA, P.R. (1975). Arginine decarboxylase from Lathyrus sativus seedlings. Purification and properites. Eur. J. Biochem., 59, 377386.
  • REGUNATHAN, S., EVINGER, M.J., MEELEY, M.P. & REIS, D.J. (1991b). Effects of clonidine and other imidazole-receptor binding agents on second messenger systems and calcium influx in bovine adrenal chromaffin cells. Biochem. Pharmacol., 42, 20112018.
  • REGUNATHAN, S., FEINSTEIN, D.L., RAASCH, W. & REIS, D.J. (1995a). Agmatine (decarboxylated arginine) is synthesized and stored in astrocytes. Neuroreport, 6, 18971900.
  • REGUNATHAN, S., FEINSTEIN, D.L. & REIS, D.J. (1999). Anti-proliferative and anti-inflammatory actions of imidazoline agents. Are imidazoline receptors involved Ann. N.Y. Acad. Sci., 881, 410419.
  • REGUNATHAN, S., MEELEY, M.P. & REIS, D.J. (1991a). Clonidine-displacing substance from bovine brain binds to imidazoline receptors and releases catecholamines in adrenal chromaffin cells. Mol. Pharmacol., 40, 884888.
  • REGUNATHAN, S., MEELEY, M.P. & REIS, D.J. (1993). Expression of non-adrenergic imidazoline sites in chromaffin cells and mitochondrial membranes of bovine adrenal medulla. Biochem. Pharmacol., 45, 16671675.
  • REGUNATHAN, S. & REIS, D.J. (1997). Stimulation of imidazoline receptors inhibits proliferation of human coronary artery vascular smooth muscle cells. Hypertension, 30, 295300.
  • REGUNATHAN, S. & REIS, D.J. (2000). Characterization of arginine decarboxylase in rat brain and liver: distinction from ornithine decarboxylase. J. Neurochem., 74, 22012208.
  • REGUNATHAN, S., SASTRE, M. & REIS, D.J. (1996b). Agmatine is released from synaptosomes and adrenal chromaffin cells by depolarization. Soc. Neurosci., (Abstr. 22): 1564.
  • REGUNATHAN, S., YOUNGSON, C., RAASCH, W., WANG, H. & REIS, D.J. (1996a). Imidazoline receptors and agmatine in blood vessels: a novel system inhibiting vascular smooth muscle proliferation. J. Pharmacol. Exp. Ther., 276, 12721282.
  • REGUNATHAN, S., YOUNGSON, C., WANG, H. & REIS, D.J. (1995b). Imidazoline receptors in vascular smooth muscle and endothelial cells. Ann. N.Y. Acad. Sci., 763, 580590.
  • REID, J.L., PANFILOV, V., MACPHEE, G. & ELLIOTT, H.L. (1995). Clinical pharmacology of drugs acting on imidazoline and adrenergic receptors. Studies with clonidine, moxonidine, rilmenidine, and atenolol. Ann. N.Y. Acad. Sci., 763, 673678.
  • REIS, D.J. & REGUNATHAN, S. (1998). Agmatine: a novel neurotransmitter Adv. Pharmacol., 42, 645649.
  • REIS, D.J., LI, G., REGUNATHAN, S., BARROW, C.J. & COOPER, R. (1994). Identifying clonidine-displacing substance. Science, 266, 462464.
  • REIS, D.J., REGUNATHAN, S. & MEELEY, M.P. (1992). Imidazole receptors and clonidine-displacing substance in relationship to control of blood pressure, neuroprotection, and adrenomedullary secretion. Am. J. Hypertens., 5, 51S57S.
  • REIS, D.J., RUGGIERO, D.A. & MORRISON, S.F. (1989). The C1 area of the rostral ventrolateral medulla oblongata. A critical brainstem region for control of resting and reflex integration of arterial pressure. Am. J. Hypertens., 2, 363S374S.
  • REIS, D.J., YANG, X.C. & MILNER, T.A. (1998). Agmatine containing axon terminals in rat hippocampus form synapses on pyramidal cells. Neurosci. Lett., 250, 185188.
  • REMAURY, A., RADDATZ, R., ORDENER, C., SAVIC, S., SHIH, J.C., CHEN, K., SEIF, I., DE MAEYER, E., LANIER, S.M. & PARINI, A. (2000). Analysis of the pharmacological and molecular heterogeneity of I(2)- imidazoline-binding proteins using monoamine oxidase-deficient mouse models. Mol. Pharmacol., 58, 10851090.
  • RUFFOLO, R.R., TUROWSKI, B.S. & PATIL, P.N. (1977). Lack of cross-desensitization between structurally dissimilar alpha- adrenoceptor agonists. J. Pharm. Pharmacol., 29, 378380.
  • RUGGIERO, D.A., REGUNATHAN, S., WANG, H., MILNER, T.A. & REIS, D.J. (1995). Distribution of imidazoline receptor binding protein in the central nervous system. Ann. N.Y. Acad. Sci., 763, 208221.
  • RUSTENBECK, I., HERRMANN, C., RATZKA, P. & HASSELBLATT, A. (1997). Imidazoline/guanidinium binding sites and their relation to inhibition of K(ATP) channels in pancreatic B-cells. Naunyn Schmiedebergs Arch. Pharmacol., 356, 410417.
  • SANCHEZ-BLAZQUEZ, P., BORONAT, M.A., OLMOS, G., GARCIA-SEVILLA, J.A. & GARZON, J. (2000). Activation of I(2)-imidazoline receptors enhances supraspinal morphine analgesia in mice: a model to detect agonist and antagonist activities at these receptors. Br. J. Pharmacol., 130, 146152.
  • SAPER, C.B., AKIL, H. & WATSON, S.J. (1986). Lateral hypothalamic innervation of the cerebral cortex: immunoreactive staining for a peptide resembling but immunochemically distinct from pituitary/arcuate alpha-melanocyte stimulating hormone. Brain Res. Bull., 16, 107120.
  • SASTRE, M., ESCRIBA, P.V., REIS, D.J. & GARCIA-SEVILLA, J.A. (1995). Decreased number and immunoreactivity of I2-imidazoline receptors in the frontal cortex of suicide victims. Ann. N.Y. Acad. Sci., 763, 520522.
  • SASTRE, M., GALEA, E., FEINSTEIN, D., REIS, D.J. & REGUNATHAN, S. (1998). Metabolism of agmatine in macrophages: modulation by lipopolysaccharide and inhibitory cytokines. Biochem. J., 330, 14051409.
  • SASTRE, M., REGUNATHAN, S., GALEA, E. & REIS, D.J. (1996b). Agmatinase activity in rat brain: a metabolic pathway for the degradation of agmatine. J. Neurochem., 67, 17611765.
  • SASTRE, M., REGUNATHAN, S. & REIS, D.J. (1997). Uptake of agmatine into rat brain synaptosomes: possible role of cation channels. J. Neurochem., 69, 24212426.
  • SASTRE, M., VENTAYOL, P. & GARCIA-SEVILLA, J.A. (1996a). Decreased density of I2-imidazoline receptors in the postmortem brain of heroin addicts. Neuroreport, 7, 509512.
  • SATISHCHANDRAN, C. & BOYLE, S.M. (1986). Purification and properties of agmatine ureohydrolyase, a putrescine biosynthetic enzyme in Escherichia coli. J. Bacteriol., 165, 843848.
  • SATRIANO, J., MATSUFUJI, S., MURAKAMI, Y., LORTIE, M.J., SCHWARTZ, D., KELLY, C.J., HAYASHI, S. & BLANTZ, R.C. (1998). Agmatine suppresses proliferation by frameshift induction of antizyme and attenuation of cellular polyamine levels. J. Biol. Chem., 273, 1531315316.
  • SCHÄFER, U., RAASCH, W., CHUN, J.K.R., DENDORFER, A., QADRI, F. & DOMINIAK, P. (1999b). The cardiovascular effects of agmatine are not mediated via peripheral binding sites but via blockade of the ganglionic transmission. Naunyn Schmiedebergs Arch. Pharmacol., 359 (Suppl): R25.
  • SCHÄFER, RAASCH, W., DENDORFER, A., QADRI, F. & DOMINIAK, P. (1998). Effects of agmatine on the cardiovascular system. Kidney Blood Press Res., 21, A131.
  • SCHÄFER, U., RAASCH, W., QADRI, F., CHUN, J. & DOMINIAK, P. (1999a). Effects of agmatine on the cardiovascular system of spontaneously hypertensive rats. Ann. N.Y. Acad. Sci., 881, 97101.
  • SCHULZ, A. & HASSELBLATT, A. (1989a). Dual action of clonidine on insulin release: suppression, but stimulation when alpha 2-adrenoceptors are blocked. Naunyn Schmiedebergs Arch. Pharmacol., 340, 712714.
  • SCHULZ, A. & HASSELBLATT, A. (1989b). An insulin-releasing property of imidazoline derivatives is not limited to compounds that block alpha-adrenoceptors. Naunyn Schmiedebergs Arch. Pharmacol., 340, 321327.
  • SCHWARTZ, D., PETERSON, O.W., MENDONCA, M., SATRIANO, J., LORTIE, M. & BLANTZ, R.C. (1997). Agmatine affects glomerular filtration via a nitric oxide synthase- dependent mechanism. Am. J. Physiol., 272, F597F601.
  • SEILER, N. & DEZEURE, F. (1990). Polyamine transport in mammalian cells. Int. J. Biochem., 22, 211218.
  • SENER, A., LEBRUN, P., BLACHIER, F. & MALAISSE, W.J. (1989). Stimulus-secretion coupling of arginine-induced insulin release. Insulinotropic action of agmatine. Biochem. Pharmacol., 38, 327330.
  • SINGH, G., HUSSAIN, J.F., MACKINNON, A., BROWN, C.M., KENDALL, D.A. & WILSON, V.G. (1995). Evidence for the presence of a non-catecholamine, clonidine-displacing substance in crude, methanolic extracts of bovine brain and lung. Naunyn Schmiedebergs Arch. Pharmacol., 351, 1726.
  • SJOHOLM, A. (1993). Role of polyamines in the regulation of proliferation and hormone production by insulin-secreting cells. Am. J. Physiol., 264, C501C518.
  • SKOGLUND, G., LUNDQUIST, I. & AHREN, B. (1988). Selective alpha 2-adrenoceptor activation by clonidine: effects on 45Ca2+ efflux and insulin secretion from isolated rat islets. Acta Physiol Scand., 132, 289296.
  • SMYTH, D.D. & PENNER, S.B. (1995). Renal I1-imidazoline receptor-selective compounds mediate natriuresis in the rat. J. Cardiovasc. Pharmacol., 26 (Suppl 2): S63S67.
  • SMYTH, D.D. & PENNER, S.B. (1999). Peripheral and central imidazoline receptor-mediated natriuresis in the rat. Ann. N.Y. Acad. Sci., 881, 344357.
  • SOBHANI, I., BADO, A., CHERIFI, Y., MOIZO, L., LAIGNEAU, J.P., POSPAI, D., MIGNON, M. & LEWIN. (1996). Helicobacter pylori stimulates gastric acid secretion via platelet activating factor. J. Physiol Pharmacol., 47, 177185.
  • SOMLYO, A.P. & SOMLYO, A.V. (1994). Signal transduction and regulation in smooth muscle. Nature, 372, 231236.
  • STEFFEN, G. & DOMINIAK, P. (1996). Significance of imidazolines for catecholamine release and for voltage-gated calcium channels in the bovine chromaffin cell. Naunyn Schmiedebergs Arch. Pharmacol., 353 (Suppl): R4.
  • STICKLE, D., BOHRER, A., BERGER, R., MORRISSEY, J., KLAHR, S. & TURK, J. (1996). Quantitation of the putative neurotransmitter agmatine as the hexafluoroacetylacetonate derivative by stable isotope dilution gas chromatography and negative-ion chemical ionization mass spectrometry. Anal. Biochem., 238, 129136.
  • STIENE-MARTIN, A., GURWELL, J.A. & HAUSER, K.F. (1991). Morphine alters astrocyte growth in primary cultures of mouse glial cells: evidence for a direct effect of opiates on neural maturation. Brain Res. Dev. Brain Res., 60, 17.
  • STIENE-MARTIN, A. & HAUSER, K.F. (1993). Morphine suppresses DNA synthesis in cultured murine astrocytes from cortex, hippocampus and striatum. Neurosci. Lett., 157, 13.
  • SUN, M.K., REGUNATHAN, S. & REIS, D.J. (1995). Cardiovascular responses to agmatine, a clonidine-displacing substance, in anesthetized rat. Clin. Exp. Hypertens., 17, 115128.
  • SYNETOS, D., MANOLOPOULOS, V.G., ATLAS, D. & PIPILI-SYNETOS, E. (1991). Human plasma-derived material with clonidine displacing substance (CDS)- like properties contracts the isolated rat aorta. J. Auton. Pharmacol., 11, 343351.
  • SZABO, B., URBAN, R., LIMBERGER, N. & STARKE, K. (1995). Cardiovascular effects of agmatine, a ”clonidine-displacing substance“, in conscious rabbits. Naunyn Schmiedebergs Arch. Pharmacol., 351, 268273.
  • TABOR, C.W. & TABOR, H. (1984). Polyamines. Annu. Rev. Biochem., 53, 749790.
  • TESSON, F., LIMON-BOULEZ, I., URBAN, P., PUYPE, M., VANDEKERCKHOVE, J., COUPRY, I., POMPON, D. & PARINI, A. (1995). Localization of I2-imidazoline binding sites on monoamine oxidases. J. Biol. Chem., 270, 98569861.
  • TESSON, F., LIMON, I. & PARINI, A. (1992). Tissue-specific localization of mitochondrial imidazoline-guanidinium receptive sites. Eur. J. Pharmacol., 219, 335338.
  • TESSON, F. & PARINI, A. (1991). Identification of an imidazoline-guanidinium receptive site in mitochondria from rabbit cerebral cortex. Eur. J. Pharmacol., 208, 8183.
  • TESSON, F., PRIP-BUUS, C., LEMOINE, A., PEGORIER, J.P. & PARINI, A. (1991). Subcellular distribution of imidazoline-guanidinium-receptive sites in human and rabbit liver. Major localization to the mitochondrial outer membrane. J. Biol. Chem., 266, 155160.
  • TOMB, J.F., WHITE, O., KERLAVAGE, A.R., CLAYTON, R.A., SUTTON, G.G., FLEISCHMANN, R.D., KETCHUM, K.A., KLENK, H.P., GILL, S., DOUGHERTY, B.A., NELSON, K., QUACKENBUSH, J., ZHOU, L., KIRKNESS, E.F., PETERSON, S., LOFTUS, B., RICHARDSON, D., DODSON, R., KHALAK, H.G., GLODEK, A., MCKENNEY, K., FITZEGERALD, L.M., LEE, N., ADAMS, M.D. & VENTER, J.C. (1997). The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature, 388, 539547.
  • TRUJILLO, K.A. (1995). Effects of noncompetitive N-methyl-D-aspartate receptor antagonists on opiate tolerance and physical dependence. Neuropsychopharmacology, 13, 301307.
  • TSOLI, E., CHAN, S.L. & MORGAN, N.G. (1995). The imidazoline I1 receptor agonist, moxonidine, inhibits insulin secretion from isolated rat islets of Langerhans. Eur. J. Pharmacol., 284, 199203.
  • ULIBARRI, I., SOTO, J., RUIZ, J., BALLESTEROS, J., JAUREGUI, J.V. & MEANA, J.J. (1999). I2-imidazoline receptors in platelets of patients with Parkinson's disease and Alzheimer's type dementia. Ann. N.Y. Acad. Sci., 881, 199202.
  • VAN BIESEN, T., HAWES, B.E., LUTTRELL, D.K., KRUEGER, K.M., TOUHARA, K., PORFIRI, E., SAKAUE, M., LUTTRELL, L.M. & LEFKOWITZ, R.J. (1995). Receptor-tyrosine-kinase- and G beta gamma-mediated MAP kinase activation by a common signalling pathway. Nature, 376, 781784.
  • VARGIU, C., CABELLA, C., BELLIARDO, S., CRAVANZOLA, C., GRILLO, M.A. & COLOMBATTO, S. (1999). Agmatine modulates polyamine content in hepatocytes by inducing spermidine/spermine acetyltransferase. Eur. J. Biochem., 259, 933938.
  • WANG, H., REGUNATHAN, S., MCGOWAN, D., BRAMWELL, S. & REIS, D.J. (1997). An antiserum to idazoxan recognizes an immunoreactive substance in human serum and cerebral spinal fluid which is not agmatine. Neurochem. Int., 30, 8594.
  • WANG, H., REGUNATHAN, S., YOUNGSON, C., BRAMWELL, S. & REIS, D.J. (1995). An antibody to agmatine localizes the amine in bovine adrenal chromaffin cells. Neurosci. Lett., 183, 1721.
  • WEITZEL, G., RENNER, R. & GUGLIELMI, H. (1971). Metabolic effects of arginine derivatives. I. Insulin like activity of arginyl compounds in vitro. Hoppe Seylers. Z. Physiol Chem., 352, 16171630.
  • WEITZEL, G., RENNER, R. & GUGLIELMI, H. (1972b). Metabolic effects of arginine derivatives. 2. Antilipolytic action of arginyl compounds. Hoppe Seylers. Z. Physiol Chem., 353, 535539.
  • WEITZEL, G., STOCK, W. & GUGLIELMI, H. (1972a). Metabolic effects of arginine derivatives. 3. Insulin-like activity of L-arginine-N,N-dialkylamides in vitro. Hoppe Seylers. Z. Physiol Chem., 353, 16611670.
  • WENNMALM, A. & JUNSTAD, M. (1976). Prostaglandin-mediated inhibition of noradrenaline release: its resistance to variations in rate of prostaglandine synthesis. Acta Physiol Scand., 97, 6065.
  • YAMAMOTO, S., NAKAO, H., YAMASAKI, K., TAKASHINA, K., SUEMOTO, Y. & SHINODA, S. (1988). Activities and properties of putrescine-biosynthetic enzymes in Vibrio parahaemolyticus. Microbiol. Immunol., 32, 675687.
  • YANG, X.C. & REIS, D.J. (1999). Agmatine selectively blocks the N-methyl-D-aspartate subclass of glutamate receptor channels in rat hippocampal neurons. J. Pharmacol Exp. Ther., 288, 544549.
  • ZEMBOWICZ, A., CHLOPICKI, S., RADZISZEWSKI, W., VANE, J.R. & GRYGLEWSKI, R.J. (1992a). NG-hydroxy-L-arginine and hydroxyguanidine potentiate the biological activity of endothelium-derived relaxing factor released from the rabbit aorta. Biochem. Biophys. Res. Commun., 189, 711716.
  • ZEMBOWICZ, A., HECKER, M., MACARTHUR, H., SESSA, W.C. & VANE, J.R. (1991). Nitric oxide and another potent vasodilator are formed from NG-hydroxy- L-arginine by cultured endothelial cells. Proc. Natl. Acad. Sci. U.S.A., 88, 1117211176.
  • ZEMBOWICZ, A., SWIERKOSZ, T.A., SOUTHAN, G.J., HECKER, M., GRYGLEWSKI, R.J. & VANE, J.R. (1992c). Mechanisms of the endothelium-dependent relaxation induced by NG-hydroxy-L-arginine. J. Cardiovasc. Pharmacol., 20 (Suppl 12): S57S59.
  • ZEMBOWICZ, A., SWIERKOSZ, T.A., SOUTHAN, G.J., HECKER, M. & VANE, J.R. (1992b). Potentiation of the vasorelaxant activity of nitric oxide by hydroxyguanidine: implications for the nature of endothelium-derived relaxing factor. Br. J. Pharmacol., 107, 10011007.
  • ZHU, Q.M., LESNICK, J.D., JASPER, J.R., MACLENNAN, S.J., DILLON, M.P., EGLEN, R.M. & BLUE, D.R. (1999). Cardiovascular effects of rilmenidine, moxonidine and clonidine in conscious wild-type and D79N alpha2A-adrenoceptor transgenic mice. Br. J. Pharmacol., 126, 15221530.